Asset
Clemidsogene Lanparvovec
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03566043 | phase2_3 | active_not_recruiting | 2018-09-27 | 2023-11-27 | REGENXBIO Inc. | CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) |
| NCT04571970 | phase1_2 | completed | 2021-03-11 | 2023-05-09 | REGENXBIO Inc. | RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome) |
FDA applications (0)
This company has no applications containing this asset.